The company is already selling its first products in Europe and is ready to expand its operations to meet global market demands. Kanabo was born out of the personal experience of founder and CEO Avih Tamir, who worked with medical cannabis in Israel - a pioneering leader in cannabinoid therapy. Israel is the first country to allow medical and scientific cannabis research, and the first country to establish a national medical cannabis program for patients. During this period, it became clear that there was a need to develop top-quality professional medical grade vaporizers. Inhalation through vaporization greatly increases the rate and speed of absorption of all the beneficial medicinal substances contained in cannabis. Kanabo's VapePod provides high bioavailability and exhibits a rapid onset of action, optimizing therapeutic efficacy and making cannabis-based treatments safer and easier than ever before. VapePod is the first approved medical device of its kind to be certified as an inhaled medical device by the Israeli Ministry of Health. It is the only device approved for vaporizing cannabis extracts that provides a safe, consistent and trusted user experience. The VapePod's loose-fill Kanabo vaporizer cartridges contain a broad spectrum hemp extract with up to 55% CBD+ cannabinoids thanks to its patented formulation.
On 1.5.2024 and 8.5.2024 we do not send any orders due to holidays and our customer support is not available. Thank you and we look forward to seeing you on the other days!
Dear Customers, we are delighted to welcome you to our e-shop with a brand new design! If you had a customer account on our website, please feel free to generate a new password to log in. As soon as you fill in your email address in the "Forgot Password" box, an email with your new login details will arrive in your inbox. We apologize for the inconvenience.
I hereby declare that I am over 18 years of age and I also declare that I am aware that the following pages may contain information about tobacco products. The sale of tobacco products and electronic cigarettes to persons under the age of 18 is prohibited pursuant to Act No. 65/2017 Coll. on measures to protect against the harm caused by tobacco products and other addictive substances and on amendments to related acts, as amended by Acts No. 225/2006 Coll., No. 274/2008 Coll. and No. 305/2009 Coll.